Core Points - Solvay has amended its €1.1 billion multilateral revolving credit facility and €0.3 billion bilateral revolving credit facilities to include sustainability-linked features, aligning with its For Generations roadmap and commitment to reducing greenhouse gas emissions [1][2] - The amendments link the company's borrowing costs to its climate goals, specifically targeting ambitious greenhouse gas emission reduction targets across Scope 1, 2, and 3 emissions [2] - The CFO of Solvay emphasized that integrating sustainability into the financing strategy enhances the company's focus on climate change, a key aspect of its For Generations strategy [3] Company Overview - Solvay is a pioneering chemical company with a history dating back to 1863, employing around 9,000 people and generating €4.7 billion in underlying net sales in 2024 [5] - The company is committed to delivering innovative and sustainable solutions that address essential global needs, including air and water purification, food preservation, health protection, and sustainable materials [5] - Solvay aims for a transition to a carbon-neutral future by 2050, highlighting its dedication to sustainability and a fair transition [5]

PresentationIt is now the time to start, so I would like to start. My name is Kobayashi from the Corporate Communications Department. I will serve as the moderator. Thank you very much for attending today's investors' meeting for the Current Priority Management Issues and Business Strategy despite your busy schedules. Today, from our President, Mito, there will be an explanation given followed by a Q&A. We plan to end this meeting at 4:00 p.m.Nobuaki MitoPresident, CEO & Representative Director And once aga ...

Business Strategy & Portfolio Upgrade - The company aims to upgrade its business portfolio with a new growth strategy, focusing on winning businesses rooted in organic synthesis technology and cultivating new growth businesses[2, 12, 14] - The company is focusing on three blockbuster candidates in the chemicals business, aiming for sales of several tens of billions of yen by 2030[16, 17] - The company aims to expand its biorationals business to 150 billion yen by FY2030, a 2X increase from 70 billion yen in FY2024[36] - The company targets a 20% market share in cutting-edge semiconductor resist[47] Financial Targets & Capital Efficiency - The company's financial targets for FY2027 include a core operating income of 200 billion yen, ROE of 8%, ROIC of 6%, and a D/E ratio of approximately 0.8X[12] - The company expects a dividend payout ratio of over 30% during the new plan period, aiming for 24 yen/share or more per year early in the future[136, 137] Structural Reforms & Resilience - Petro Rabigh is undergoing financial improvements, including a $1.5 billion loan write-off and a $702 million contribution from the sale of approximately 22.5% of PRC to Aramco[111, 113] - The company is integrating its domestic PP and LLDPE businesses into Prime Polymer, expecting cost reductions of over 8 billion yen per year[115, 119] Advanced Medical Solutions - The company is deploying a winning CDMO strategy leveraging its strengths in advanced small molecule APIs and oligonucleotide CDMO, focusing on high-purity long-chain nucleotides[55, 69] - The company aims for its Parkinson's disease therapy using iPS cells to grow into a blockbuster with 100 billion yen in sales in the 2030s[102]

Core Viewpoint - A securities class action lawsuit has been filed against Dow Inc. for allegedly making false and misleading statements regarding its financial condition and ability to manage macroeconomic challenges during the Class Period from January 30, 2025, to July 23, 2025 [1][3]. Group 1: Allegations Against Dow Inc. - The lawsuit claims that Dow overstated its ability to mitigate macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [3]. - It is alleged that the negative impacts of competitive pressures, softening global sales, and product oversupply on Dow's business were understated [3]. - The complaint asserts that Dow's public statements were materially false and misleading throughout the Class Period [3]. Group 2: Legal Process and Participation - Investors in Dow have until October 28, 2025, to seek appointment as lead plaintiff or remain absent class members [4]. - The lead plaintiff represents the interests of all class members and selects counsel to direct the litigation [4]. - Participation as a lead plaintiff does not affect the ability to share in any recovery from the lawsuit [4].

Company Overview - LyondellBasell Industries N.V. is a chemical company with a global presence, operating across six business segments including Olefins and Polyolefins [1] Business Segments - The company has a diverse product lineup that spans the plastics and petrochemical value chain, indicating a comprehensive approach to the chemical industry [1] Investment Insights - The company is positioned to identify long-term investment opportunities, particularly in sectors that offer safe and growing dividends, which may appeal to risk-adjusted return investors [1]

Company Overview - LyondellBasell Industries N.V. is a chemical company with a global presence, operating across six business segments including Olefins and Polyolefins [1] Business Segments - The company has a diverse product lineup that spans the plastics and petrochemical value chain, indicating a broad operational scope [1] Investment Insights - The company is positioned in the market to identify long-term investment opportunities, particularly in sectors that offer safe and growing dividends [1]

Summary of Key Points from Conference Call Records Industry Overview - **Industry**: Chemical Industry, specifically focusing on MDI (Methylene Diphenyl Diisocyanate) and companies like DuPont and Huntsman - **Key Events**: US Department of Commerce's preliminary determination in the anti-dumping investigation of MDI from China Company-Specific Insights Huntsman Corporation (HUN) - **MDI Import Data**: Approximately 400kt of MDI was imported last year, with around 75% sourced from China [1] - **Preliminary Dumping Rates**: Covestro and Wanhua faced dumping rates of 376.12%, while other Chinese exporters faced rates of 511.75% [1] - **Future Expectations**: A favorable outcome in the investigation could lead to a final ruling by February or March next year, effective for five years [1] DuPont (DD) - **Investor Day Insights**: DuPont's business remains compelling with potential upside on a Sum-of-the-Parts (SOTP) basis [2] - **Stock Rating**: Maintained a "Buy" rating ahead of the spin-off, with a target price of $93.00, indicating a potential upside of 19.1% from the current price of $78.10 [2][29] - **Financial Flexibility**: The divestiture of the AM&C segment is expected to improve financial flexibility for share repurchases and M&A activities [2] Ecovyst (ECVT) - **Stock Rating Change**: Downgraded from "Buy" to "Neutral" following the announcement of the AM&C segment sale [2] - **Future Outlook**: The remaining Ecoservices business is expected to generate steady cash flow with high earnings predictability [2] Economic Indicators - **Housing Market**: Housing starts and building permits fell by approximately 9% and 4% month-over-month in August, indicating potential weakness in the construction sector [3] - **Retail Sales**: Retail sales increased by 0.6% month-over-month in August, exceeding expectations [9] - **Industrial Production**: Increased by 0.1% month-over-month in August, with capacity utilization remaining flat at 77.4% [9] Other Notable Developments - **LIRC Update**: Zijin Mining commenced production at the Tres Quebradas project in Argentina, with a capacity of 20ktpa LCE [9] - **OLN and Mitsui**: The Blue Water Alliance joint venture will end by the end of the year, allowing OLN to focus on long-term structural opportunities [9] - **Huntsman Product Launch**: Huntsman's Advanced Materials segment launched a new range of ARALDITE epoxy adhesives that are free from BPA and classified CMR substances [9] Market Performance - **Stock Performance YTD**: Notable declines in stock prices for companies like Huntsman (-41.0%) and Dow (-39.0%) indicate challenges in the chemical sector [30] This summary encapsulates the critical insights and developments from the conference call records, providing a comprehensive overview of the chemical industry and specific companies involved.

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the upcoming lead plaintiff deadline on October 28, 2025, for a class action lawsuit [1][2] Group 1: Class Action Details - Investors who bought Dow Inc. securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 28, 2025 [2] - The lawsuit alleges that Dow made false and misleading statements regarding its financial flexibility and the impact of macroeconomic factors on its business [4] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise [3]

Core Viewpoint - A class action securities lawsuit has been filed against Dow Inc. alleging securities fraud that negatively impacted investors between January 30, 2025, and July 23, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [2]. - It is alleged that the true extent of negative impacts from competitive pressures, declining global sales, and product oversupply was understated [2]. - The defendants' public statements are claimed to have been materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Dow Inc. securities between January 30, 2025, and July 23, 2025, of the upcoming lead plaintiff deadline on October 28, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Dow securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 28, 2025 [3]. - The lawsuit claims that Dow made false and misleading statements regarding its ability to manage macroeconomic and tariff-related challenges, overstating its financial flexibility and understating the negative impacts on its business [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4].